JHU

Design Day

Johns Hopkins Engineering Design Day is the Whiting School’s premier event that showcases the innovative works of Hopkins engineering students. Come to see how students implement their classroom knowledge, creativity, and problem-solving skills to develop inventions and processes that solve real-world problems and create a better future.​​

Event information will be posted here when available.

SAVE THE DATE
JHU Design Day is
April 29, 2025

Feeding Hope: Addressing Food Insecurity in Baltimore

In collaboration with J.C. Faulk and the Bmore Community Food group, a team of multidisciplinary students have been challenged to build a seamless food distribution device and system that can offer sustenance to individuals at any hour. The goal of the distribution system is to break down stereotypes of people experiencing food insecurity and instead empower, unite, and build resilience in Baltimore against hunger and social challenges.

Remora: Providing Autonomy for Quadruple Amputees in the Shower

Dave, a quadruple amputee and veteran of the US Army and Coast Guard, currently takes 1 hour to perform his shower routine with the help of his caregiver. Additionally, there are no shower prosthetics on the market to help him bathe autonomously. In partnership with the Disabled American Veterans (DAV), engineering students at Johns Hopkins designed the Remora, a waterproof upper-limb prosthetic system that allows for autonomous cleansing in the shower for quadruple amputees. The system features a harness which secures the prosthetic to the user, a loosely fitted arm case that allows water to drain, and detachable terminal ends that allow the user to switch between a hook and a brush depending on the user’s bathing needs.

Parkinetics: Better Monitoring of Parkinson’s Disease Patients at Home

Parkinson Disease (PD) is an incurable neurodegenerative disorder characterized by severe motor symptoms that affects approximately one million Americans. Medication is available to mitigate these symptoms but must be readjusted frequently as patient responsiveness wanes over time. However, neurologists have limited scope of information to determine the optimal dosing scheme for their patients, given their dependence on unreliable and incomplete self-reported symptoms. This can result in underprescription, leading to the return of debilitating symptoms, or overprescription, causing adverse drug effects. Thus, neurologists need an objective way to monitor at-home mobility of PD patients in order to precisely adjust medication. We propose a novel sensor system to monitor the motor symptoms of PD patients as they engage in activities of daily living (ADLs). Analysis of longitudinal symptom progression will be presented to clinicians on a dashboard to aid in the informed adjustment of medication, improving quality of life.

Sustained Dilation of Schlemm’s Canal

ViscoCure’s mission is to prevent avoidable, irreversible blindness. Glaucoma describes progressive vision loss due predominantly to elevated pressure in the front of the eye. Glaucoma is a leading cause of blindness worldwide, projected to represent over 110 million individuals by 2040 with an estimated market valuation of 5.8 billion USD. Glaucoma is an incurable chronic disease, and treatments aim to reduce pressure in the eye in order to prevent vision loss. ViscoCure aims to provide efficacious, cost-effective treatment for glaucoma patients. Ultimately, ViscoCure addresses the shortcoming of competing procedures and reduces the reliance on strict compliance with eye drop medication, a key pitfall of glaucoma management. Our method effectively drops intraocular pressure in a method that preserves the natural anatomy of the eye, is cost effective, minimally invasive, and a longer-term treatment irrespective of eye pigmentation.